Cardiovascular disease (CVD) is the top cause of death globally. The World Health Organization (WHO) (2017) noted that CVD was responsible for 17.7 million deaths in 2015. CVDs include coronary heart disease (heart attack), cerebrovascular disease (stroke), elevated blood pressure (hypertension), peripheral artery disease, rheumatic heart disease, congenital heart disease, and heart failure (WHO, 2017). This noncommunicable disease is expected to remain the main cause of death and to account for 23.3 million deaths worldwide by 2030.

About 80% of noncommunicable diseases occur in low- and middle-income countries, including Indonesia, and 37% of these deaths are caused by CVD. Integrated actions and strategies are needed to decrease the incidence of CVD. Identification of the key factors driving CVD is crucial, and preventive action is mandatory to decrease mortality and to limit the impact of morbidity caused by CVD.

Complex factors can influence the effectiveness of strategies aimed at managing CVD in developing countries, and it is imperative to integrate ideas, knowledge, and strategies to address the burden of disease associated with CVD. The Faculty of Medicine Universitas Islam Indonesia is presenting the Third International Conference on Cardiovascular Disease as a forum for clinicians, researchers, lecturers, students, and policy makers to gather, share, and discuss the current information about managing CVD in developing countries. The overall theme of this event is “Multidisciplinary approaches to address the burden of cardiovascular disease in developing countries”.

The objectives of the conference are as follows.

1. to update knowledge about the relevant program priorities for addressing CVD burden in developing countries
2. to explore options for the comprehensive management of primary cardiovascular risk factors such as high blood pressure, high blood glucose level, smoking, and sedentary lifestyle
3. to discuss the latest guidance and evidence on the early detection and management of CVD and its implementation in the context of developing countries, including the impact of the COVID-19 pandemic on the management of CVD
4. to strengthen interprofessional collaboration in addressing challenges using multidisciplinary approaches for the prevention, treatment, and rehabilitation of patients with CVD
5. to update knowledge about health technology science and innovation related to the management and rehabilitation of patients with CVD.